All members have the option of attending our various HTC-centric events which include:
Date: Wednesday, November 29, 2023
Time: 1:00pm – 2:00pm ET
TITLE:
Overview of Adzynma (rADAMTS13) Prescribing Information
OBJECTIVE:
Inform on the new approval and prescribing information of Adzynma indicated for prophylactic and on-demand use for patients with congenital TTP.
TARGET AUDIENCE:
Hematologists, NPs, nurses, pharmacists
SPEAKER:
Ali Mokdad, MD, PhD, MBA, Medical Director, Takeda
